Sleep apnea Board decisions

The Board has determined that the Veteran's sleep apnea was not incurred or aggravated during his active service and is not related to any service-connected disability. As a result, the claim for service connection for sleep apnea is denied.

The Veteran's appeal is being remanded for additional development to assess the severity of his service-connected conditions, including sleep apnea, hearing loss, and chronic rhinitis. The case will be readjudicated after this development.

The Board finds that the evidence is at least in equipoise as to whether the Veteran's obstructive sleep apnea was caused by his active duty service, and thus grants service connection for this condition.

The Board has decided to remand the case for additional development, including obtaining VA treatment records and an addendum opinion from a clinician regarding the etiology of the Veteran's sleep apnea.

The Veteran's claims for service connection are being remanded due to the need for additional development and medical inquiry.

The Veteran's appeal has been withdrawn by the Veteran, resulting in the dismissal of the case.

The Veteran's claim for an initial rating in excess of 30 percent for DDD of the lumbosacral spine was denied. However, service connection for arthritis of the thoracic spine was granted.

The Board has determined that the Veteran does not have soft tissue sarcoma and his skin disorders did not manifest during active service or are causally related to his military service. Therefore, the claim for service connection is denied.

The Board has determined that the Veteran's obstructive sleep apnea had its onset during active duty service and granted service connection for this condition.

The Board has determined that the Veteran's sleep apnea had onset during a period of active service and granted service connection for this condition. The issue of an initial compensable rating for nocturnal enuresis is remanded.

The case is being remanded for additional development, including obtaining verification of the Veteran's periods of active duty and scheduling examinations to determine the nature and etiology of his back condition, acquired psychiatric disorder, sleep apnea, and bilateral lower extremity radiculopathy.

The Veteran's service-connected disabilities do not render him unable to secure or follow substantially gainful employment.

The Board has determined that the Veteran's current diagnosis of obstructive sleep apnea is at least in equipoise with the evidence, and therefore service connection for this condition is granted.

The Veteran's service connection for sleep apnea and hypertension (HTN) have been denied. The Board found that the Veteran's acquired psychiatric disorder, including PTSD, anxiety disorder, and MDD, warrants a disability rating of 50 percent prior to June 13, 2017.

The Veteran's service-connected obstructive sleep apnea with asthma was found to meet the criteria for a 60 percent disability rating from December 5, 2014 to December 4, 2015. Prior to that date, the predominant condition was obstructive sleep apnea.

The Veteran's appeal has been dismissed as he requested withdrawal of the appeal.

The Veteran's claims for service connection are mixed, with some issues granted and others not.,The appeal involves multiple conditions including low back/lumbar spine condition, dizziness, neck and cervical spine pathology, sleep apnea, headaches, and memory loss.

The Veteran's lumbosacral sprain with IVDS and DDD warrants a rating of 40 percent, but no higher. The service connection for right ankle degenerative changes is granted. Service connection for left ankle degenerative changes as secondary to the right ankle disability is also granted.

The Veteran's appeal is being remanded for further development, including obtaining additional medical records and a clinical opinion regarding the relationship between his PTSD and sleep apnea.

The Veteran withdrew his appeals concerning the claims of entitlement to service connection for sleep apnea and to a rating in excess of 70 percent for bipolar disorder.